Giiant Pharma Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
2ndary - Private
- Investors
-
10
Giiant Pharma General Information
Description
Developer of gut-restricted, small molecule therapeutics designed to improve the tolerability and efficacy of treatments for inflammatory bowel diseases (IBD). The company's platform offers precision delivery technology, utilizing the gut microbiota to bioactivate and release drugs in specific lower GI tract locations and releases the specific active form in the colon at the site of inflammation, enabling IBD patients to experience safe and effective treatments with minimal systemic exposure.
Contact Information
Website
www.giiant.comCorporate Office
- 630 René-Lévesque Boulevard West
- 20th Floor
- Montreal, Quebec H3B 1S6
- Canada
Corporate Office
- 630 René-Lévesque Boulevard West
- 20th Floor
- Montreal, Quebec H3B 1S6
- Canada
Giiant Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Secondary Transaction - Private | Completed | Pre-Clinical Trials | ||||
| 2. Seed Round | 30-Jun-2021 | Completed | Pre-Clinical Trials | |||
| 1. Seed Round | 18-Dec-2020 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Giiant Pharma Comparisons
Industry
Financing
Details
Giiant Pharma Competitors (4)
One of Giiant Pharma’s 4 competitors is Edesa Biotech, a Formerly VC-backed company based in Markham, Canada.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Edesa Biotech | Formerly VC-backed | Markham, Canada | ||||
| Aclaris Therapeutics | Formerly VC-backed | Wayne, PA | ||||
| Athersys | Formerly VC-backed | Cleveland, OH | ||||
| Pfizer | Corporation | New York, NY |
Giiant Pharma Patents
Giiant Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| ES-2989065-T3 | Bioactivated pde4 inhibitor precursors from the intestinal microbiota | Active | 28-May-2020 | ||
| JP-2023528397-A | Bioactivating pde4 inhibitor precursors of the gut microbiota | Active | 28-May-2020 | ||
| JP-7762168-B2 | Bioactive pde4 inhibitor precursors from gut microbiota | Active | 28-May-2020 | ||
| AU-2021280418-A1 | Gut microbiota bioactivated pde4 inhibitor precursors | Pending | 28-May-2020 | ||
| CA-3174137-A1 | Gut microbiota bioactivated pde4 inhibitor precursors | Active | 28-May-2020 | C07H17/02 |
Giiant Pharma Signals
Giiant Pharma Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| AmorChem | Venture Capital | Minority | ||
| Anges Québec | Angel Group | Minority | ||
| AQC Capital | Venture Capital | Minority | ||
| CQDM | Not-For-Profit Venture Capital | Minority | ||
| Crystal Pharmatech | VC-Backed Company | Minority |
Giiant Pharma FAQs
-
When was Giiant Pharma founded?
Giiant Pharma was founded in 2014.
-
Where is Giiant Pharma headquartered?
Giiant Pharma is headquartered in Montreal, Canada.
-
What is the size of Giiant Pharma?
Giiant Pharma has 4 total employees.
-
What industry is Giiant Pharma in?
Giiant Pharma’s primary industry is Drug Discovery.
-
Is Giiant Pharma a private or public company?
Giiant Pharma is a Private company.
-
What is Giiant Pharma’s current revenue?
The current revenue for Giiant Pharma is .
-
How much funding has Giiant Pharma raised over time?
Giiant Pharma has raised $12.1M.
-
Who are Giiant Pharma’s investors?
AmorChem, Anges Québec, AQC Capital, CQDM, and Crystal Pharmatech are 5 of 10 investors who have invested in Giiant Pharma.
-
Who are Giiant Pharma’s competitors?
Edesa Biotech, Aclaris Therapeutics, Athersys, and Pfizer are competitors of Giiant Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process